9-136431131-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_019892.6(INPP5E):​c.1550-14C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00103 in 1,575,526 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0012 ( 2 hom., cov: 31)
Exomes 𝑓: 0.0010 ( 16 hom. )

Consequence

INPP5E
NM_019892.6 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.336

Publications

0 publications found
Variant links:
Genes affected
INPP5E (HGNC:21474): (inositol polyphosphate-5-phosphatase E) The protein encoded by this gene is an inositol 1,4,5-trisphosphate (InsP3) 5-phosphatase. InsP3 5-phosphatases hydrolyze Ins(1,4,5)P3, which mobilizes intracellular calcium and acts as a second messenger mediating cell responses to various stimulation. Studies of the mouse counterpart suggest that this protein may hydrolyze phosphatidylinositol 3,4,5-trisphosphate and phosphatidylinositol 3,5-bisphosphate on the cytoplasmic Golgi membrane and thereby regulate Golgi-vesicular trafficking. Mutations in this gene cause Joubert syndrome; a clinically and genetically heterogenous group of disorders characterized by midbrain-hindbrain malformation and various associated ciliopathies that include retinal dystrophy, nephronophthisis, liver fibrosis and polydactyly. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2016]
INPP5E Gene-Disease associations (from GenCC):
  • Joubert syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Ambry Genetics
  • MORM syndrome
    Inheritance: AR Classification: DEFINITIVE, MODERATE, SUPPORTIVE, LIMITED Submitted by: G2P, ClinGen, Genomics England PanelApp, Ambry Genetics, Orphanet
  • COACH syndrome 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Joubert syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Joubert syndrome with ocular defect
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 9-136431131-G-A is Benign according to our data. Variant chr9-136431131-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 261199.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00124 (187/151408) while in subpopulation AMR AF = 0.00808 (122/15106). AF 95% confidence interval is 0.00691. There are 2 homozygotes in GnomAd4. There are 110 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_019892.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
INPP5E
NM_019892.6
MANE Select
c.1550-14C>T
intron
N/ANP_063945.2
INPP5E
NM_001318502.2
c.1547-14C>T
intron
N/ANP_001305431.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
INPP5E
ENST00000371712.4
TSL:1 MANE Select
c.1550-14C>T
intron
N/AENSP00000360777.3Q9NRR6-1
INPP5E
ENST00000930360.1
c.1571-14C>T
intron
N/AENSP00000600419.1
INPP5E
ENST00000910890.1
c.1547-14C>T
intron
N/AENSP00000580949.1

Frequencies

GnomAD3 genomes
AF:
0.00122
AC:
184
AN:
151292
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000267
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00789
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00117
Gnomad SAS
AF:
0.000830
Gnomad FIN
AF:
0.00248
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000192
Gnomad OTH
AF:
0.00240
GnomAD2 exomes
AF:
0.00360
AC:
890
AN:
247214
AF XY:
0.00294
show subpopulations
Gnomad AFR exome
AF:
0.000441
Gnomad AMR exome
AF:
0.0202
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000985
Gnomad FIN exome
AF:
0.00362
Gnomad NFE exome
AF:
0.000171
Gnomad OTH exome
AF:
0.00431
GnomAD4 exome
AF:
0.00100
AC:
1429
AN:
1424118
Hom.:
16
Cov.:
25
AF XY:
0.000919
AC XY:
653
AN XY:
710630
show subpopulations
African (AFR)
AF:
0.000245
AC:
8
AN:
32706
American (AMR)
AF:
0.0184
AC:
814
AN:
44250
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25870
East Asian (EAS)
AF:
0.00188
AC:
74
AN:
39448
South Asian (SAS)
AF:
0.00131
AC:
112
AN:
85346
European-Finnish (FIN)
AF:
0.00290
AC:
152
AN:
52396
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5696
European-Non Finnish (NFE)
AF:
0.000155
AC:
167
AN:
1079278
Other (OTH)
AF:
0.00173
AC:
102
AN:
59128
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
79
158
236
315
394
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00124
AC:
187
AN:
151408
Hom.:
2
Cov.:
31
AF XY:
0.00149
AC XY:
110
AN XY:
73946
show subpopulations
African (AFR)
AF:
0.000267
AC:
11
AN:
41250
American (AMR)
AF:
0.00808
AC:
122
AN:
15106
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00117
AC:
6
AN:
5132
South Asian (SAS)
AF:
0.000831
AC:
4
AN:
4814
European-Finnish (FIN)
AF:
0.00248
AC:
26
AN:
10492
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000192
AC:
13
AN:
67834
Other (OTH)
AF:
0.00238
AC:
5
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.522
Heterozygous variant carriers
0
9
18
26
35
44
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00210
Hom.:
2
Bravo
AF:
0.00295

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
INPP5E-related disorder (1)
-
-
1
Joubert syndrome (1)
-
-
1
Joubert syndrome 1 (1)
-
-
1
not provided (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
10
DANN
Benign
0.38
PhyloP100
0.34
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.11
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs181576122; hg19: chr9-139325583; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.